SCHEMBL22944883

SCHEMBL22944883

c1ccc(-c2ccc(-c3nc4ccccc4nc3-c3cc(N4c5cc6ccccc6cc5-c5cccc6cccc4c56)cc4ccccc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE6D O43924 1/20 0.42
L3MBTL1 Q9Y468 7/20 0.36
KDM4E B2RXH2 5/20 0.35
LMNA P02545 5/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 6/20 0.34
GAA P10253 2/20 0.34
MAPK1 P28482 3/20 0.34
HPGD P15428 3/20 0.34
TSHR P16473 2/20 0.34
CASP1 P29466 2/20 0.34
HIF1A Q16665 2/20 0.34
HSD17B10 Q99714 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.32
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21515236 0.93 PDE6D (0.44) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL26737300 0.90 PDE6D (0.41) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22945526 0.88 PDE6D (0.54) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22944764 0.87 PDE6D (0.43) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22945528 0.87 PDE6D (0.52) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22944763 0.86 PDE6D (0.37) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22945667 0.85 PDE6D (0.37) PDE6DL3MBTL1ALDH1A1MAPK1HPGD
SCHEMBL22945665 0.84 PDE6D (0.38) PDE6DL3MBTL1ALDH1A1MAPK1HPGD
SCHEMBL22944888 0.83 L3MBTL1 (0.39) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL21515232 0.83 PDE6D (0.44) PDE6DL3MBTL1KDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812658-B2 Compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-11812658-B2 Compound and organic light emitting diode comprising same LG CHEM, LTD. (KR) 2023-11-07 US disclosed
US-20210036236-A1 COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LG CHEM, LTD. (KR) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036236-A1 COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME DRD1, DRD3, DRD2 PDE6D 342/4885L3MBTL1 339/4885KDM4E 1857/4885
US-11812658-B2 Compound and organic light emitting diode comprising same DRD1, DRD3, DRD2 PDE6D 342/4885L3MBTL1 339/4885KDM4E 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.